740 Organometallics, Vol. 29, No. 4, 2010
Sun et al.
1375 (m), 1316 (m), 1137 (m), 1038 (m), 851 (m), 776 (m), 690
(m), 655 (m). Mp: 140-141 °C. Anal. Calcd (%) for C20H20N2O:
C, 78.92; H, 6.62; N, 9.20. Found: C, 78.88; H, 6.86; N, 9.10.
2-(1H-Benzo[d]imidazol-2-yl)-N-(2,4,6-trimethylphenyl)quino-
line-8-carboxamide (L4): 1H NMR (CDCl3, 400 MHz): δ 13.65
(s, N-H, 1H, amide), 11.64 (s, N-H, 1H, imidazole), 8.77 (d,
J = 8.6 Hz, 1H, quin), 8.62 (d, J = 7.3 Hz, 1H, quin), 8.53 (d,
J = 8.6 Hz, 1H, quin), 8.30 (d, J = 8.1 Hz, 1H, quin), 7.84 (t, J =
7.7 Hz, 1H, quin), 7.69 (m, 2H, aryl), 7.31-7.30 (m, 2H, aryl),
6.97 (s, 2H, aryl), 2.28 (s, 9H, CH3). 13C NMR (CDCl3, 100
MHz): δ 164.0, 150.8, 149.4, 145.0, 139.6, 138.2, 135.6, 135.3,
134.4, 132.6, 131.2, 129.0, 128.8, 127.6, 120.7, 21.1, 19.1. FT-IR
(KBr, cm-1): 3060 (m), 2916 (m), 1639 (s), 1600 (m), 1565 (m),
1529 (m), 1500 (m), 1417 (m), 1315 (m), 1273 (m), 1210 (w), 1143
(w), 1115 (m), 905 (w), 856 (m), 745 (s), 655 (m). Mp: 234-235
°C. Anal. Calcd (%) for C26H22N4O: C, 76.83; H, 5.46; N, 13.78.
Found: C, 76.88; H, 5.60; N, 13.69.
(CDCl3, 400 MHz): δ 12.25 (s, N-H, 1H, amide), 10.50 (s, N-H,
1H, imidazole), 8.90 (d, J =7.3Hz, 1H, quin), 8.68 (d, J =8.6Hz,
1H, quin), 8.50 (d, J = 8.6 Hz, 1H, quin), 8.10 (d, J = 8.1 Hz, 1H,
quin), 7.92 (d, J = 7.7 Hz, 1H, aryl), 7.78 (dd, J1 = 7.6 Hz, J2 =
7.6 Hz, 1H, quin), 7.60 (d, J = 7.7 Hz, 1H, aryl), 7.41 (dd, J1 = 7.1
Hz, J2 =8.6Hz, 1H, aryl), 7.36 (dd, J1 = 8.3Hz, J2 = 7.3 Hz, 1H,
aryl), 7.31-7.24 (m, 1H, aryl), 7.17 (d, J = 8.9 Hz, 2H, aryl). 13C
NMR (CDCl3, 100 MHz): δ 165.0, 155.5, 150.0, 148.3, 144.7,
139.2, 138.3, 134.5, 132.8, 128.9, 128.8, 127.3, 127.2, 119.9, 111.7.
FT-IR (KBr, cm-1): 3238 (m), 3049 (w), 2954 (w), 1665 (s), 1602
(m), 1566 (m), 1534 (w), 1499 (w), 1473 (m), 1415 (m), 1318 (m),
1248 (m), 1109 (w), 1038 (w), 1009 (s), 853 (m), 820 (w), 744 (m),
703 (w), 655 (m). Mp: 202-203 °C. Anal. Calcd (%) for
C23H14F2N4O: C, 69.00; H, 3.52; N, 13.99. Found: C, 69.11; H,
3.58; N, 13.90.
3.3. Synthesis of Complexes (C1-C7). (η5-Cyclopentadienyl)-
[2-(benzimidazol-2-yl)-N-(2,6-diisopropylphenyl)quinoline-8-carboxi-
midate]chlorotitanium (C1). To a THF solution (30 mL) of 2-(1H-
benzo[d]imidazol-2-yl)-N-(2,6-diisopropylphenyl)quinoline-8-
carboxamide (0.449 g, 1.00 mmol) was added KH (0.080 g, 2.00
mmol) at -78 °C. The mixture was allowed to warm to room
temperature and stirred for additional 2 h. At -78 °C, 20 mL of a
THF solution of CpTiCl3 (0.219 g, 1.00 mmol) was added dropwise
over a 30 min period. The resultant mixture was allowed to warm to
room temperature and stirred for 12 h. The residue, obtained by
removing the solvent under vacuum, was extracted with CH2Cl2
(3 ꢀ 20 mL), and the combined filtrates were concentrated under
vacuum to reduce the volume to 20 mL. n-Heptane (45 mL) was
layered, and several days later, dark red crystals were obtained
(0.396 g, 0.665 mmol, yield 66.5%). 1H NMR (CDCl3, 400 MHz): δ
9.21 (d, J = 7.4 Hz, 1H, quin), 8.55 (s, 2H, quin), 8.10 (d, J = 7.9
Hz, 1H, quin), 7.96 (d, J = 8.0 Hz, 1H, quin), 7.82 (d, J = 7.2 Hz,
1H, aryl), 7.80 (d, J = 7.5 Hz, 1H, aryl), 7.33 (d, J = 7.4 Hz, 1H,
aryl), 7.29-7.26 (m, 1H, aryl), 7.19-7.12 (m, 3H, aryl), 6.23 (s, 5H,
Cp), 3.51 (m, 1H, CH(CH3)2), 2.83 (m, 1H, CH(CH3)2), 1.42 (m,
6H, CH(CH3)2), 1.23 (m, 3H, CH(CH3)2), 0.99 (m, 3H, CH-
(CH3)2). 13C NMR (CDCl3, 100 MHz): δ 154.3, 143.0, 142.8,
137.8, 137.3, 136.0, 132.3, 129.9, 129.2, 128.4, 128.3, 127.7, 125.4,
125.2, 123.7, 123.2, 122.5, 121.1, 120.0, 119.5, 118.9, 118.7, 32.0, 29.8,
23.1, 22.8, 21.5, 14.3. Anal. Calcd (%) for C34H31ClN4OTi: C, 68.64;
H, 5.25; N, 9.42. Found: C, 68.63; H, 5.28; N, 9.43.
2-(1H-Benzo[d]imidazol-2-yl)-N-phenylquinoline-8-carboxamide
(L5). Similarly, aniline was used instead of 2,6-diisopropylbenzen-
amine to prepare 2-methyl-N-phenylquinoline-8-carboxamide in
71.0% yield. Then 2-methyl-N-phenylquinoline-8-carboxamide
reacts with o-phenylenediamine to prepare 2-(1H-benzo[d]-
imidazol-2-yl)-N-phenylquinoline-8-carboxamide (L5) in 60.1%
yield. 2-Methyl-N-phenylquinoline-8-carboxamide: 1H NMR
(CDCl3, 400 MHz): δ 14.05 (s, N-H, 1H, amide), 8.92 (d, J =
7.4 Hz, 1H, quin), 8.20 (d, J = 8.4 Hz, 1H, quin), 7.95 (d, J = 8.0
Hz, 1H, quin), 7.89 (m, 2H, aryl and quin), 7.66 (t, J = 7.6 Hz, 1H,
quin), 7.42 (m, 3H, aryl), 7.15 (t, J = 8.0 Hz, 1H, aryl), 2.90 (s, 3H,
CH3). 13C NMR (CDCl3, 100 MHz): δ 164.5, 158.4, 144.2, 139.5,
138.0, 133.9, 132.1, 129.1, 127.7, 126.8,125.8, 123.8, 121.9, 120.2,
25.4. FT-IR (KBr, cm-1): 3064 (w), 2921 (m), 1670 (s), 1619 (m),
1594 (m), 1558 (s), 1499 (m), 1489 (m), 1444 (m), 1374 (m), 1330
(m), 1308 (m), 1267 (m), 1237 (w), 1137 (m), 1030 (w), 910 (m), 874
(m), 779 (m), 751 (s), 688 (m), 664 (m). Mp: 109-110 °C. Anal.
Calcd (%) for C17H14N2O: C, 77.84; H, 5.38; N, 10.68. Found: C,
77.82; H, 5.60; N, 10.69. 2-(1H-Benzo[d]imidazol-2-yl)-N-phenyl-
1
quinoline-8-carboxamide (L5): H NMR (CDCl3, 400 MHz): δ
13.62 (s, N-H, 1H, amide), 13.44 (s, N-H, 1H, imidazole), 8.80
(d, J = 8.5 Hz, 1H, quin), 8.72 (d, J = 7.3 Hz, 1H, quin), 8.49 (d,
J = 8.5 Hz, 1H, quin), 8.31-8.29 (m, 3H, ph and quin), 7.85 (t,
J = 7.6 Hz, 1H, quin), 7.82-7.70 (m, 2H, aryl), 7.46 (t, J = 7.4 Hz,
2H, aryl), 7.36-7.34 (m, 2H, aryl), 7.15 (t, J = 7.2 Hz, 1H, aryl).
13C NMR (CDCl3, 100 MHz): δ 163.5, 161.1, 158.3, 153.0, 150.3,
148.2, 144.7, 139.9, 138.1, 134.2, 132.9, 129.7, 129.2, 128.6, 127.7,
124.0, 120.0, 111.5. FT-IR (KBr, cm-1): 3088 (m), 2910 (m), 1654
(s), 1618 (m), 1568 (m), 1531 (m), 1501 (m), 1418 (m), 1310 (m),
1270 (m), 1215 (w), 1145 (w), 1112 (m), 895 (w), 856 (m), 747 (s),
651 (m). Mp: 166 °C. Anal. Calcd (%) for C23H16N4O: C, 75.81; H,
4.43; N, 15.38. Found: C, 75.85; H, 4.48; N, 15.66.
2-(1H-Bbenzo[d]imidazol-2-yl)-N-(2,6-difluorophenyl)quinoline-
8-carboxamide (L6). Similarly, 2,6-difluorobenzenamine was
used instead of 2,6-diisopropylbenzenamine to prepare 2-methyl-
N-difluorophenylquinoline-8-carboxamide in 72.0% yield. 2-
Methyl-N-difluorophenylquinoline-8-carboxamide reacted with
o-phenylenediamine to give 2-(1H-benzo[d]imidazol-2-yl)-N-phenyl-
quinoline-8-carboxamide (L6) in 46.0% yield. 2-Methyl-N-di-
fluorophenylquinoline-8-carboxamide: 1H NMR (CDCl3, 400
MHz): δ 13.63 (s, N-H, 1H, amide), 8.87 (d, J = 7.3 Hz, 1H,
quin), 8.17 (d, J = 8.4 Hz, 1H, quin), 7.95 (d, J = 8.0 Hz, 1H,
quin), 7.63 (t, J = 7.6 Hz, 1H, quin), 7.37 (d, J = 8.4 Hz, 1H,
quin), 7.20 (m, 1H, aryl), 7.03 (d, J = 8.0 Hz, 1H, aryl), 7.01 (d,
J = 8.0 Hz, 1H, aryl), 2.80 (s, 3H, CH3). 13C NMR (CDCl3, 100
MHz): δ 164.3, 159.1, 158.9, 156.6, 144.9, 138.0, 134.3, 132.5,
127.4, 126.8, 126.5, 125.8, 122.1, 111.9, 25.4. FT-IR (KBr, cm-1):
3080 (w), 2915 (m), 1671 (s), 1617 (m), 1599 (m), 1568 (m), 1516
(s), 1435 (m), 1375 (m), 1321 (m), 1268 (m), 1138 (m), 1037 (m),
851 (m), 808 (m), 776 (m), 687 (m), 651 (m). Mp: 131-132 °C.
Anal. Calcd (%) for C17H12F2N2O: C, 68.45; H, 4.05; N, 9.39.
Found: C, 68.29; H, 4.06; N, 9.69. 2-(1H-Benzo[d]imidazol-2-yl)-
N-(2,6-difluorophenyl)quinoline-8-carboxamide (L6): 1H NMR
η5-Cyclopentadienyl[2-(benzimidazol-2-yl)-N-(2,6-diethylphe-
nyl)quinoline-8-carboximidate] chlorotitanium (C2). Using the
same procedure for the synthesis of C1, C2 was obtained as a
dark red solid in 60.5% yield. 1H NMR (CDCl3, 400 MHz): δ
9.36 (d, J = 6.0 Hz, 1H, quin), 8.43 (d, J = 6.9 Hz, 1H, quin),
8.14 (d, J = 7.5 Hz, 1H, quin), 8.08 (d, J = 6.0 Hz, 1H, quin),
7.81 (m, 1H, aryl), 7.38-7.36 (m, 3H, aryl), 6.96 (t, J = 7.0 Hz,
1H, quin), 6.89 (d, J = 7.2 Hz, 1H, aryl), 6.71 (m, 1H, aryl), 6.04
(m, 1H, aryl), 5.86 (s, 5H, Cp), 3.27-3.17 (m, 1H, CH(CH3)2),
2.96-2.90 (m, 1H, CH(CH3)2), 2.68-2.60 (m,1H, CH(CH3)2),
2.49-2.45 (m, 1H, CH(CH3)2), 1.57 (t, J = 7.3 Hz, 3H, CH-
(CH3)2), 1.07 (t, J = 7.2 Hz, 3H, CH(CH3)2). 13C NMR (CDCl3,
100 MHz): δ 165.0, 150.8, 149.4, 144.4, 141.6, 139.5, 135.7,
135.4, 132.6, 132.0, 131.7, 129.4, 128.7, 127.5, 127.2, 126.1,
125.8, 124.3, 122.8, 120.7, 120.1, 112.7, 24.9, 14.6. Anal. Calcd
(%) for C32H27ClN4OTi: C, 67.80; H, 4.80; N, 9.88. Found: C,
67.73; H, 4.80; N, 9.82.
η5-Cyclopentadienyl[2-(benzimidazol-2-yl)-N-(2,6-dimethyl-
phenyl)quinoline-8-carboximidate]chlorotitanium (C3). Using
the same procedure for the synthesis of C1, C3 was obtained
as a dark red solid in 58.0% yield. 1H NMR (CDCl3, 400 MHz):
δ 9.22 (d, J = 6.9 Hz, 1H, quin), 8.54 (s, 2H, quin), 8.09 (d, J =
7.4 Hz, 1H, quin), 7.95 (d, J = 7.7 Hz, 1H, aryl), 7.82-7.80 (m,
1H, aryl), 7.34 (t, J = 7.1 Hz, 1H, quin), 7.30-7.26 (m, 1H,
aryl), 7.14 (d, J = 7.3 Hz, 2H, aryl), 7.04 (d, J = 7.0 Hz, 2H,
aryl), 6.22 (s, 5H, Cp), 2.39 (s, 6H, CH3). 13C NMR (CDCl3, 100
MHz): δ 155.4, 146.7, 145.0, 144.8, 143.2, 142.7, 138.0, 137.2,
135.5, 132.5, 129.9, 129.2, 128.4, 128.0, 127.6, 125.5, 125.2,
123.7, 121.2, 119.9, 118.9, 118.6, 19.0. Anal. Calcd (%) for